Richard Christopher's Net Worth
$2.73 Million
Who is Richard Christopher?
Richard Christopher has an estimated net worth of $2.73 Million. This is based on reported shares across multiple companies, which include ICAD INC, INVIVO THERAPEUTICS HOLDINGS CORP., DUSA PHARMACEUTICALS INC, LUCID INC, and Lexaria Bioscience Corp..
SEC CIK
Richard Christopher's CIK is 0001271244
Past Insider Trading and Trends
2010 was Richard Christopher's most active year for acquiring shares with 4 total transactions. Richard Christopher's most active month to acquire stocks was the month of February. 2011 was Richard Christopher's most active year for disposing of shares, totalling 18 transactions. Richard Christopher's most active month to dispose stocks was the month of April. 2018 saw Richard Christopher paying a total of $199,665.64 for 88,333 shares, this is the most they've acquired in one year. In 2012 Richard Christopher cashed out on 523,052 shares for a total of $2,278,516.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ICAD INC (ICAD) Snapshot price: $1.48
Executive VP and CFORichard Christopher owns 117,854 units of Common Stock which is worth $174,423.92 and 129,498 units of Commom Stock which is worth $191,657.04. In the year 2016 Richard Christopher filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
| -4.00% | -4.91K |
$4.08 | -$20,028.72 | 117.85K |
Dec 5
| |||
Form 4
| +25.71% | 51.6K |
$3.08 | $158,921.84 | 252.26K |
Mar 30
| |||
Form 4
| +54.15% | 25K |
—
|
—
| 71.17K |
Mar 22
| |||
Form 4
| -10.49% | -5.41K |
$3.52 | -$19,039.68 | 46.16K |
Dec 5
| |||
Form 4
| +3.15% | 1.57K |
—
|
—
| 51.57K |
May 4
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) No price found
Chief Financial OfficerRichard Christopher owns 5,220 units of Common Stock. In the year 2019 Richard Christopher filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
| +229.55% | 3.64K |
—
|
—
| 5.22K |
Mar 10
| |||
Form 4
|
∞
| 47.5K |
—
|
—
| 47.5K |
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DUSA PHARMACEUTICALS INC No price found
VP Finance & CFORichard Christopher owns 272,522 units of Restricted Stock Award. Richard Christopher used to own units in Common Stock but no longer holds any shares there.acquired a total of 384,650 shares in DUSA PHARMACEUTICALS INC at a cost of $87,161.00, Richard also disposed a total of 342,650 shares of DUSA PHARMACEUTICALS INC equalling to $2,570,609.92.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -276.01K |
$8.00 | -$2,208,096.00 |
0
|
Dec 20
| |||
Form 4
| +2.79% | 7.5K |
$1.60 | $12,000.00 | 276.01K |
Nov 13
| |||
Form 4
| -0.38% | -1.03K |
$6.13 | -$6,313.90 | 268.51K |
May 9
| |||
Form 4
| -1.09% | -2.98K |
$5.86 | -$17,462.80 | 269.54K |
Mar 13
| |||
Form 4
| +43.02% | 124.85K |
$6.05 | -$31,163.55 | 415.04K |
Mar 7 - Mar 8
| |||
Form 4
| -2.20% | -3.33K |
$4.65 | -$15,479.85 | 147.67K |
Mar 5
| |||
Form 4
|
—
|
0
|
$3.74 | -$187,593.15 | 151K |
May 12
| |||
Form 4
| -0.68% | -1.03K |
$5.80 | -$5,985.60 | 151K |
May 9
| |||
Form 4
| -1.93% | -2.98K |
$4.15 | -$12,387.75 | 152.03K |
Mar 13
| |||
Form 4
| +33.63% | 61.67K |
$3.95 | -$13,169.30 | 245.04K |
Mar 4 - Mar 7
| |||
Form 4
| -1.09% | -1.03K |
$2.01 | -$2,074.32 | 93.35K |
May 9
| |||
Form 4
| -3.29% | -3.21K |
$1.78 | -$5,722.70 | 94.39K |
Mar 12
| |||
Form 4/A
| +75.54% | 42K |
—
|
—
| 97.6K |
Mar 5
| |||
Form 4
| +75.54% | 42K |
—
|
—
| 97.6K |
Mar 5
| |||
Form 4
| +208.89% | 37.6K |
—
|
—
| 55.6K |
Mar 13
| |||
Form 4
| +6.39% | 5K |
$2.00 | $10,000.00 | 83.25K |
Aug 18
| |||
Form 4
|
∞
| 13K |
—
|
—
| 13K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LUCID INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexaria Bioscience Corp. (LEXX) Snapshot price: $3.26
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||